Skip to main content

Table 2 Association between sNfL levels and type 2 DM and their combined effect on all-cause mortality

From: The association between joint Serum Neurofilament Light Chain and type 2 diabetes with all-cause and cardiovascular mortality in US adults: a longitudinal study of NHANES

 

Crude

 

Model 1

HR (95% CI)

P value

 

HR (95% CI)

P value

sNfL levels

     

 Continuous sNfL

3.21(2.47,4.18)

< 0.001

 

3.04(2.14,4.33)

< 0.001

 Not elevated

1 [Reference]

  

1 [Reference]

 

 Elevated

5.60(2.50,12.53)

< 0.001

 

4.38(2.04,9.39)

< 0.001

type 2 DM

   

 No

1 [Reference]

  

1 [Reference]

 

 Yes

3.13(1.48,6.60)

0.003

 

2.49(1.23,5.05)

0.011

sNfL and type 2 DM

 

 No type 2 DM

1 [Reference]

  

1 [Reference]

 

 type 2 DM and not elevated

1.25(0.50, 3.11)

0.626

 

1.14(0.45,2.93)

0.778

 type 2 DM and elevated

5.10(2.39,10.89)

< 0.001

 

3.79(1.88,7.65)

< 0.001

  1. Abbreviations: HR, hazard ratio; CI, confidence interval; sNfL, serum neurofilament light chain; DM, diabetes mellitus; Model 1 was adjusted for age (20–59 or ≥ 60), sex (male or female), and race (Non-Hispanic White, Non-Hispanic Black or Other). Elevated sNfL is characterized by values exceeding the median sNfL. Elevated sNfL is characterized by values exceeding the median sNfL